Overview

Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study was to assess the reproducibility of quantitative measurements of myocardial uptake of Iobenguane I 123 on planar and single photon emission computed tomography (SPECT) imaging following intravenous (i.v.) administration of AdreView. Efficacy was assessed based upon the absolute differences between quantitative analyses of imaging data on 2 scans performed 5 to 14 days apart.
Phase:
Phase 4
Details
Lead Sponsor:
GE Healthcare
Collaborators:
H2O Clinical LLC
Quintiles, Inc.
Treatments:
3-Iodobenzylguanidine